1,4-Benzoquinone reductase from basidiomycete Phanerochaete chrysosporium: spectral and kinetic analysis.
B J Brock, M H Gold
Index: Arch. Biochem. Biophys. 331(1) , 31-40, (1996)
Full Text: HTML
Abstract
The reaction mechanism of a 1,4-benzoquinone reductase from the wood-rotting basidiomycete Phanerochaete chrysosporium was investigated. The native, oxidized, FMN-containing enzyme was reduced quantitatively by NADH and the resulting reduced enzyme was reoxidized in the presence of one equivalent of 2,6-di-methoxy-1,4-benzoquinone (DMBQ). The stoichiometry of NADH oxidation versus DMBQ reduction is 1:1. The enzyme catalyzes the reduction of quinones to hydroquinones by a ping-pong steady-state mechanism. However, inhibition is observed at low NADH concentrations. Quinone products derived from the autooxidation of the unstable compounds 1,2,4-trihydroxybenzene and 5-chloro-2,3,4-trihydroxybenzene also appear to be substrates for the quinone reductase. The enzyme reduces the one-electron acceptors ferricyanide and ferricytochrome c (Cc3+) with rates of 58.4 and 0.08%, respectively, compared to DMBQ. The stoichiometry of NADH oxidation versus ferricyanide reduction is 1:2. In the presence of quinones the rates of Cc3+ and ferricyanide reduction are increased, owing to the nonenzymatic reduction of these acceptors by enzyme-generated hydroquinone products. Dicumarol and Cibacron blue are competitive inhibitors with respect to NADH, with Ki values of 2.1 and 0.30 microM, respectively. Reconstitution of the apoprotein with FMN yields a fully active enzyme at an FMN-to-protein ratio of 2:1, suggesting that the flavin content of the enzyme is two molecules of FMN per dimer.
Related Compounds
Related Articles:
Oxidative depolymerization of lignin in ionic liquids.
2010-06-21
[ChemSusChem 3(6) , 719-23, (2010)]
Quinonoid constituents as contact sensitisers in Australian blackwood (Acacia melanoxylon RBR).
1981-05-01
[Br. J. Ind. Med. 38(2) , 105-9, (1981)]
1984-09-01
[Arch. Dermatol. 120(9) , 1206-8, (1984)]
1998-01-01
[Proc. Soc. Exp. Biol. Med. 217(1) , 89-96, (1998)]
1988-03-01
[J. Pharmacol. Exp. Ther. 244(3) , 1011-5, (1988)]